RECRUITING

ASCENT Intervention for Brain Tumor Patients

Description

The goal of this study is to refine and test a psychosocial intervention called ASCENT (ACT-based Supportive intervention for patients with CENTral nervous system tumors). This intervention was developed to help patients after being diagnosed with a brain tumor. The main question this study aims to answer is whether this intervention is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in 6 coaching sessions and complete short surveys at four different time points. Some participants will be asked to share feedback via interviews.

Study Overview

Study Details

Study overview

The goal of this study is to refine and test a psychosocial intervention called ASCENT (ACT-based Supportive intervention for patients with CENTral nervous system tumors). This intervention was developed to help patients after being diagnosed with a brain tumor. The main question this study aims to answer is whether this intervention is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in 6 coaching sessions and complete short surveys at four different time points. Some participants will be asked to share feedback via interviews.

An ACT-Based Supportive Intervention for Patients With Central Nervous System Tumors

ASCENT Intervention for Brain Tumor Patients

Condition
Malignant Brain Tumor
Intervention / Treatment

-

Contacts and Locations

Boston

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States, 02114

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age ≥ 18
  • * Massachusetts General Hospital Cancer Center Patient
  • * Within 6 months of diagnosis of malignant primary Central Nervous System (CNS) tumor
  • * English speaking
  • * Inability to provide informed consent as assessed by the study team (e.g., due to severe cognitive impairment/dementia)
  • * Moderate to severe receptive aphasia (Quick Aphasia Battery sentence comprehension subscale \< 8)
  • * Current or imminent hospice enrollment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Massachusetts General Hospital,

Deborah A Forst, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

2029-07-31